How Goldman Currently Rates Cooper (NYSE:COO)
New York: Cooper (NYSE:COO) coverage was started with a Neutral rating by professional analysts at Goldman. This was disseminated in analysts report on Thursday, 17 December.
From a total of 11 analysts covering Cooper (NYSE:COO) stock, 10 rate it a ”Buy”, 0 a “Sell”, and 4 a ”Hold”. This means that 71% of the ratings are positive. The highest target price is $183 while the lowest target price is $136. The mean of all analyst targets is $158.64 with a 9.98% above today’s ($136.91) stock price. Cooper was the topic of 16 analyst reports since August 26, 2015 according to the firm StockzIntelligence Inc. Piper Jaffray maintained shares on December 4 with “Overweight” rating. Wells Fargo downgraded COO stock in a recent report from November 17 to “Market Perform” rating. Finally, Zacks downgraded the stock to “Hold” rating in a report issued on an August 31.
Approximately 264,336 shares of stock traded hands. Cooper Companies Inc (NYSE:COO) has declined 23.52% since May 14, 2015 and is downtrending. It has underperformed by 21.26% the S&P500.
The overall sentiment of institutions has increased to 1.13 in Q2 2015. Its up 0.21, from 0.92 in 2015Q2. The ratio increased, as 31 institutions have sold all the shares of Cooper Companies Inc that they owned while 121 funds have taken shares off the table. 45 funds have purchased shares for the first time while 126 added to their positions. These institutions now hold 58.18 million shares or 23.43% more than the 47.13 million shares they owned in 2015Q2.
The Fund Blue Jay Capital Management Llc currently is holding shares equating to 7.02% of its total portfolio in Cooper Companies Inc representing a total of 120,000 shares. Another fund,Nebula Capital Management Lp, is holding a total of 45,200 shares equating to 4.54% of their holdings. Additionally, Taurus Asset Management Llc has a 82,655 share stake in Cooper Companies Inc which represents 2.38% of their total portfolio. The Fund, Torray Llc, based out of Maryland, has also built up a stake in the stock, which represents a total of 2.37% of their total portfolio. Finally Orbimed Advisors Llc, a fund which is based in the state of New York reported a total holdings of 1.30 million shares.
Insider activity is a very important aspect to track on any stock. Going back to March 10, 2015, shareholders of Cooper Companies Inc have witnessed 0 buys, and a total of 3 insider sales equating to a net activity of approximately $2.78 million . Rubenstein Allan E sold 294 shares worth approximately $44,100. Rosenberg Steven sold 17,500 shares worth approximately $2.62M. Matz Gregory W sold 10,000 shares worth approximately $1.76 million. Weiss Robert S sold 67,500 shares worth approximately $12.59M. The company insider Bender A Thomas sold 7,000 shares worth $1.30M.
The Cooper Companies, Inc. , is a global medical device company. The company has a market cap of $6.70 billion. The Firm operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). It has 33.1 P/E ratio. CooperVision is a global maker providing products for contact lens wearers.
According to Zacks Investment Research, “The Cooper Companies, Inc., through its principal subsidiaries, develops, manufactures and markets healthcare products. CooperVision markets a range of contact lenses to correct visual defects, specializing in toric lenses that correct astigmatism. The company also markets conventional toric and spherical lenses and lenses for patients with more complex vision disorders. CooperSurgical markets diagnostic products, surgical instruments and accessories to the women’s healthcare market.”